Varian Ends First Quarter Down 1 Percent

Varian Medical Systems, the Palo Alto-based maker of oncology and X-ray equipment, announced first quarter net earnings were down 1 percent from last year. Revenues for the quarter were $625 million, up 8 percent from the same period a year ago, but net earnings were still down, according to a company press release. Varian’s oncology services dominated its line of business, accounting for $488 million in first quarter revenue, followed by x-ray services at $113 million. "While we met our guidance for net earnings and revenues, this was a challenging quarter for the company in a variety of ways," says Tim Guertin, president and CEO of Varian Medical Systems, according to the release. "We experienced order push outs in our North American oncology business and X-Ray Product orders and sales were hurt by inventory adjustments by our customers in Japan.”

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.